Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: Relation to basal serum cholestanol

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 20, Issue 5, 2000, Pages 1340-1346

  Miettinen, Tatu A ^a   Strandberg, T E ^a   Gylling, H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cholestanol; Cholesterol lowering; Lathosterol; Simvastatin; Sitosterol

Indexed keywords

CHOLESTANOL; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LATHOSTEROL; PHYTOSTEROL; SIMVASTATIN; SITOSTEROL; STEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG EFFICACY; HUMAN; ISCHEMIC HEART DISEASE; LIPID ABSORPTION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0034019728     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.20.5.1340     Document Type: Article

References (37)

1. Miettinen TA. Detection of changes in human cholesterol metabolism. Ann Clin Res. 1970;2:300-320.
2. Miettinen TA. Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions. Ann Clin Res. 1971; 3:264-271.
3. Miettinen TA, Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolaemic patients with ileal bypass. In: Paumgartner G, Stiehl A, Gerok W, eds. Bile Acids and Cholesterol in Health and Disease. Lancaster, England: MTP Press; 1983:183-187.
4. Vuoristo M, Miettinen TA. Serum cholesterol precursor sterols in coeliac disease: effects of gluten-free diet and cholestyramine. Gut. 1986;27: 1312-1319.
5. Gylling H, Miettinen TA. Serum noncholesterol sterols related to cholesterol metabolism in familial hypercholesterolemia. Clin Chim Acta. 1988;178:41-50.
6. Färkkilä MA, Tilvis RS, Miettinen TA. Raised plasma cholesterol precursors in patients with gut resections. Gut. 1988;29:188-195.
7. Kempen HJM, Glatz JFC, Leuven JAG, Voort van der HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res. 1988;29:1149-1155.
8. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990; 131:20-31.
9. Björkhem I, Miettinen TA, Reihner E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res. 1987;28: 1137-1143.
10. Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr. 1986;43:92-97.
11. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men. Metabolism. 1989;38:136-140.
12. Miettinen TA, Strandberg T, Vanhanen HT, Gylling H, for the 4S Group. Noncholesterol serum sterols in Scandinavian Simvastatin Survival Study. In: Gotto AM, Paoletti R, Smith LC, Catapano AL, Jackson AS, eds. Drugs Affecting Lipid Metabolism: Risk Factors and Future Directions. Norwell, Mass: Kluwer Academic Publishers; 1996:473-476.
13. Miettinen TA, Gylling H, Strandberg T, Sarna S, for the Finnish 4S Investigators. Baseline serum cholestanol predicts recurrent coronary events in a subgroup of the Scandinavian Simvastatin Survival Study (4S). BMJ. 1998;316:1127-1130.
14. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
15. The Scandinavian Simvastatin Survival Study Group. Design and baseline results of the Scandinavian Simvastatin Survival Study of patients with stable angina and/or previous myocardial infarction. Am J Cardiol. 1993;71:393-400.
16. Miettinen TA. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res. 1988;29:43-51.
17. Pedersen TR, Olsson AG, Faergeman O, Kjekshus J, Wedel H, Berg K, Wilhelmsen L, Haghfelt T, Thorgeirsson G, Pyorala K, Miettinen T. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation. 1998;97:1453-1460.
18. Vanhanen HT, Miettinen TA. Cholesterol absorption and synthesis during pravastatin, gemfibrozil and their combination. Atherosclerosis. 1995; 115:135-146.
19. Miettinen TA, Vanhanen H, Ojala J-P, Tikkanen MJ. Non-cholesterol sterols and faecal elimination of cholesterol during statin and fibrate treatment. Atherosclerosis. 1992;97:S73-S80.
20. Vanhanen H, Kesäniemi YA, Miettinen TA. Pravastatin lowers serum cholesterol, cholesterol-precursor sterols, fecal steroids, and cholesterol absorption in man. Metabolism. 1992;41:588-595.
21. Uusitupa MIJ, Miettinen TA, Happonen P, Ebeling T, Turtola H, Voutilainen E, Pyörälä K. Lathosterol and other noncholesterol sterols during treatment of hypercholesterolemia with lovastatin alone and with cholestyramine or guar gum. Arterioscler Thromb. 1992;12:807-813.
22. Réihner E, Rudling M, Ståhlberg D, Berglund L, Ewerth S, Björkhem I, Einarsson K, Angelin B. Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol. N Engl J Med. 1990;323:224-228.
23. Miettinen TA. Cholesterol production in obesity. Circulation. 1974;44: 842-850.
24. 3H] cholesterol in rabbits. Biochim Biophys Acta. 1988;963:35-41.
25. Ishida F, Sato A, Iizuka Y, Kitani K, Sawasaki Y, Kamei T. Effects of MK-733 (Simvastatin), an inhibitor of 3-hydroxy-3-methylgluratyl coenzyme A reductase, on intestinal acylcoenzyme A:cholesterol acyltransferase activity in rabbits. Biochim Biophys Acta. 1989;1004: 117-123.
26. Gylling H, Miettinen TA. The effects of inhibiting cholesterol synthesis and absorption on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin dependent diabetic men. J Lipid Res. 1996;37: 1776-1785.
27. Miettinen TA, Kesäniemi YA. Cholesterol absorption: regulation of cholesterol synthesis and elimination and within-population variations of serum cholesterol levels. Am J Clin Nutr. 1989;49:629-635.
28. Miettinen TA. Regulation of serum cholesterol by cholesterol absorption. In: Parnham MJ, Niemann R, eds. Agents and Actions Supplements: AAS 26. Basel, Switzerland: Birkhäuser Verlag; 1988:53-65.
29. Björkhem I, Boberg KM. Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995:2073-2099.
30. Lütjohann D, von Bergmann K. Phytosterolaemia. Diagnosis, characterization and therapeutic approaches. Ann Med. 1997;29:181-184.
31. Glueck CJ, Speirs J, Tracy T, Streicher P, Illig E, Vandegrift J. Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives. Metabolism. 1991;40: 842-848.
32. Patel SB, Salen G, Hikada H, Kwiterovich Jr PO, Stalenhoef AFH, Miettinen TA, Grundy SM, Lee M-H, Rubenstein JS, Polymeropoulos MH, Brownstein MJ. Mapping a gene involved in regulating dietary cholesterol absorption: the sitosterolemia locus is found at chromosome 2p21. J Clin Invest. 1998;102:1041-1044.
33. Grundy SM, Bilheimer DW. Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance. Proc Natl Acad Sci USA. 1984;81:2538-2542.
34. Miettinen TA. Cholesterol and bile acid synthesis in two families with homozygous and heterozygous hypercholesterolemia. Arteriosclerosis. 1984;4:383-388.
35. Gylling H, Siimes M, Miettinen TA. Sitostanol ester margarine in dietary hypolipidemic treatment of children with familial hypercholesterolemia. J Lipid Res. 1995;36:1807-1812.
36. Gylling H, Rajaratnam R, Miettinen TA. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation. 1997;96:4226-4231.
37. Gylling H, Miettinen TA. Sitostanol ester added to long term simvastatin treatment of coronary patients with low and high basal cholesterol absorption. Atherosclerosis. 1997;134:157. Abstract.